Pfreundschuh Peter P.
- SEC CIK
- 0001585839
No open-market purchases or sales filed in the past year.
Current role at each company
- YMAB Y-mAbs Therapeutics, Inc.EVP, CFO and Treasureras of Sep 18, 2025
- VYGR Voyager Therapeutics, Inc.Chief Financial Officeras of Feb 22, 2024
- KRRO Korro Bio, Inc.Chief Financial Officeras of Feb 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pfreundschuh Peter P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VYGR Voyager Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 (view filing) | Feb 21 | 1 day | Pfreundschuh Peter P.Chief Financial Officer | SSale | −3.76K | $7.46 | −$28.1K | −2.1%175.7K after | |
| Oct 5, 2023 (view filing) | Oct 3 | 2 days | Pfreundschuh Peter P.Chief Financial Officer | SSale | −13.6K | $6.99 | −$94.8K | −8.3%149.4K after |
KRRO Korro Bio, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 (view filing) | Feb 18-22 | 5 days | Pfreundschuh Peter P.Chief Financial Officer | SSale | −2.95K | $3.70 | −$10.9K | −24.8%8.93K after | 2 lots |
| Feb 18, 2022 (view filing) | Feb 16-17 | 2 days | Pfreundschuh Peter P.Chief Financial Officer | SSale | −2.52K | $4.31 | −$10.9K | −17.5%11.9K after | 2 lots |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Pfreundschuh Peter P.Chief Financial Officer | SSale | −1.35K | $4.33 | −$5.83K | −8.6%14.4K after |